Publication Name	World Journal of Clinical Oncology
Manuscript ID	89466
Country	Italy

Received	2023-11-01 20:40
Peer-Review Started	2023-11-01 20:43
To Make the First Decision
Return for Revision	2023-11-29 01:42
Revised	2023-12-07 10:25
Second Decision	2023-12-24 23:31
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2024-01-02 06:51
Articles in Press	2024-01-02 06:51
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-13 12:56
Publish the Manuscript Online	2024-01-23 04:13

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Uveal melanoma: Recent advances in immunotherapy
Manuscript Source	Invited Manuscript
All Author List	Francesco Saverio Sorrentino, Francesco De Rosa, Patrick Di Terlizzi, Giacomo Toneatto, Andrea Gabai, Lucia Finocchio, Carlo Salati, Leopoldo Spadea and Marco Zeppieri
ORCID	Author(s) ORCID Number Francesco De Rosa http://orcid.org/0000-0003-0511-1298 Carlo Salati http://orcid.org/0000-0003-4736-5296 Leopoldo Spadea http://orcid.org/0000-0002-1190-3956 Marco Zeppieri http://orcid.org/0000-0003-0999-5545
Funding Agency and Grant Number
Corresponding Author	Marco Zeppieri, BSc, MD, PhD, Doctor, Department of Ophthalmology, University Hospital of Udine, p.le S. Maria della Misericordia 15, Udine 33100, Italy. markzeppieri@hotmail.com
Key Words	Uveal melanoma; Immunotherapy; Ocular oncology; Tumor; Metastatic disease; Genetic mutations
Core Tip	Our minireview will cover the latest studies about immunotherapy for uveal melanoma (UM) metastatic disease. Driver genes and oncogenic mutations have been largely investigated. Up to half of affected patients develop metastases that are the leading single cause of death after diagnosis of UM. Precise systemic therapy addressing metastatic UM and significantly improving the surveillance is not available for each single case. However, identifying predictive factors, achieving international consensus on surveillance protocols, aiming to inactivate micrometastases, and standardizing outcomes would be crucial to be able to effectively cure metastatic UM.
Publish Date	2024-01-23 04:13
Citation	Sorrentino FS, De Rosa F, Di Terlizzi P, Toneatto G, Gabai A, Finocchio L, Salati C, Spadea L, Zeppieri M. Uveal melanoma: Recent advances in immunotherapy. World J Clin Oncol 2024; 15(1): 23-31
URL	https://www.wjgnet.com/2218-4333/full/v15/i1/23.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i1.23

Full Article (PDF)	WJCO-15-23-with-cover.pdf
Full Article (Word)	WJCO-15-23.docx
Manuscript File	89466_Auto_Edited-YJP.docx
Answering Reviewers	89466-Answering reviewers.pdf
Audio Core Tip	89466-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	89466-Conflict-of-interest statement.pdf
Copyright License Agreement	89466-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate	89466-Language certificate.pdf
Peer-review Report	89466-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	89466-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	89466-Bing-Wang JJ-2.png
Scientific Editor Work List	89466-Scientific editor work list.pdf